MEDICINES CO's ticker is MDCO and the CUSIP is 584688105. A total of 296 filers reported holding MEDICINES CO in Q4 2019. The put-call ratio across all filers is 0.95 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $960,000 | +112.4% | 11,300 | -25.8% | 0.19% | +122.4% |
| Q3 2018 | $452,000 | +97.4% | 15,220 | +130.6% | 0.08% | +63.5% |
| Q2 2018 | $229,000 | +44.9% | 6,600 | +14.1% | 0.05% | +44.4% |
| Q4 2017 | $158,000 | -36.3% | 5,786 | -20.7% | 0.04% | +16.1% |
| Q4 2016 | $248,000 | +15.3% | 7,300 | +28.1% | 0.03% | +10.7% |
| Q3 2016 | $215,000 | -57.3% | 5,700 | -61.9% | 0.03% | -60.0% |
| Q2 2016 | $503,000 | +49.3% | 14,960 | +41.1% | 0.07% | +79.5% |
| Q1 2016 | $337,000 | +1.5% | 10,600 | -8.6% | 0.04% | -11.4% |
| Q2 2015 | $332,000 | -25.9% | 11,600 | -27.5% | 0.04% | -45.7% |
| Q1 2015 | $448,000 | – | 16,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 4,202,000 | $356,917,000 | 29.62% |
| SYQUANT CAPITAL SAS | 505,030 | $42,897,000 | 22.09% |
| Moab Capital Partners | 521,987 | $44,338,000 | 17.51% |
| Antipodean Advisors LLC | 321,000 | $27,266,000 | 15.60% |
| RAMIUS ADVISORS LLC | 419,826 | $35,660,000 | 15.34% |
| DLD Asset Management, LP | 3,275,900 | $278,255,000 | 15.00% |
| Foresite Capital Management IV, LLC | 403,217 | $34,249,000 | 14.78% |
| WHITE SQUARE CAPITAL LLP | 239,331 | $20,329,000 | 14.70% |
| Davide Leone & Partners Investment Co Ltd. | 1,146,192 | $97,358,000 | 12.50% |
| Quad Capital Management Advisors LLC | 8,640 | $734,000 | 11.19% |